There are several different forms of eye diseases, such as the wet form of age-related macular degeneration (fAMD), diabetic macular edema (DME) and retinal vein occlusion (RVO) which result in new vessel formation in the area of the macula (the place of sharpest vision). Due to the leakiness of the vessels, damp and potentially blood will infiltrate the surrounding tissue. This results in swelling of the retina and consequently dysfunction of cells with responsibility for vision.
The growth of these pathological vessels is induced by the messenger VEGF (Vascular Endothelial Growth Factor). VEGF inhibitors are injected directly in the eye of the patient. The inhibition of the messenger VEGF leads to reduced vascular malformations and swelling of the retina. These drugs have to be administered regularly every month. If patients remain untreated this can result in vision loss. Due to the more advanced age of most patients, visual performance is already restricted at the beginning of the therapy.
The patient care program provides individual talks via telephone on the basis of information brochures and related materials. Our service center discusses the difficulties related to dealing with vision loss with patients and their relatives.